Detalles de la búsqueda
1.
Hyper-CVAD versus dose-adjusted EPOCH as initial treatment for adults with acute lymphoblastic leukemia.
Eur J Haematol
; 111(6): 863-871, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37670560
2.
Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemia.
Cancer
; 128(7): 1411-1417, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34931301
3.
Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility.
Haematologica
; 106(8): 2114-2120, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32646891
4.
Financial Implications of Early Hospital Discharge After AML-Like Induction Chemotherapy: A 4-Year Retrospective Analysis.
J Natl Compr Canc Netw
; : 1-10, 2021 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34161925
5.
Current treatment strategies for measurable residual disease in patients with acute myeloid leukemia.
Cancer
; 125(18): 3121-3130, 2019 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31291012
6.
Improvements in the early death rate among 9380 patients with acute myeloid leukemia after initial therapy: A SEER database analysis.
Cancer
; 121(12): 2004-12, 2015 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25739348
7.
Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms.
Haematologica
; 104(4): e143-e146, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30409798
8.
Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203.
Leukemia
; 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38830960
9.
Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial.
JAMA Oncol
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38722664
10.
Intensive Reinduction Chemotherapy Followed by Early Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory High-Grade Myeloid Neoplasms.
Transplant Cell Ther
; 2024 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38710302
11.
Unsatisfactory efficacy in randomized study of reduced-dose CPX-351 for medically less fit adults with newly diagnosed acute myeloid leukemia or other high-grade myeloid neoplasm.
Haematologica
; 103(3): e106-e109, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29242304
12.
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification.
Leukemia
; 37(9): 1915-1918, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37524919
13.
Poor post-induction outcomes in patients with acute myeloid leukemia previously treated with hypomethylating agents.
Leuk Lymphoma
; 64(5): 990-996, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36891630
14.
Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML.
Blood Adv
; 7(17): 4950-4961, 2023 09 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37339483
15.
Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia.
Leuk Lymphoma
; 64(5): 927-937, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36938892
16.
An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.
Transplant Cell Ther
; 29(4): 279.e1-279.e10, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36572384
17.
Comparative analysis of infectious complications with outpatient vs. inpatient care for adults with high-risk myeloid neoplasm receiving intensive induction chemotherapy.
Leuk Lymphoma
; 63(1): 142-151, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34608844
18.
Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms.
Cancers (Basel)
; 14(12)2022 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35740603
19.
Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies.
Clin Cancer Res
; 27(8): 2190-2199, 2021 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33451977
20.
Accuracy of SIE/SIES/GITMO Consensus Criteria for Unfitness to Predict Early Mortality After Intensive Chemotherapy in Adults With AML or Other High-Grade Myeloid Neoplasm.
J Clin Oncol
; 38(35): 4163-4174, 2020 12 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33030979